A new, highly infectious subvariant of omicron is raising concerns among scientists and health experts as it spreads in India and other countries, including the U.S. Scientists say the variant Read more
Tag: PFE
With BA.5 the dominant variant, hospitalizations hike up to 4-month high
While the daily averages of new COVID-19 cases and deaths remained in relatively tight ranges, hospitalizations jumped to a four-month high, and the positivity rate of tests climbed to a Read more
COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high
While the daily average of new COVID-19 cases have settled back into a low-100K range that has lasted for about seven weeks, hospitalizations took their first dip since mid-April and Read more
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases in the coming months
The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week that included putting billions of dollars toward Read more
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases in the coming months
The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week that included putting billions of dollars toward Read more
Pfizer submits a new NDA to FDA for COVID-19 pill PAXLOVID
Pfizer Inc. PFE, +0.55% said Thursday that it has submitted a New Drug Application (NDA) for COVID-19 treatment pills PAXLOVID for patients at high risk for progression to severe illness. Read more
FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron
The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots that better protect against omicron and its subvariants, according to a recommendation from a Food and Read more